300289.SZ深圳证券交易所 · 创业板 ChiNext
Beijing Leadman Biochemistry 利德曼
Medical Devices 医疗器械
¥5.92−¥0.02 · −0.34%
Open 开盘
¥5.94
High 最高
¥6.04
Low 最低
¥5.89
Prev Close 昨收
¥5.94
Volume 成交量
347.0万股
Turnover 成交额
¥2,062.8万
Mkt Cap 总市值
¥32亿
P/E 市盈率
−124.6×
Recent Activity 近期动态All Filings 全部公告 →
8 significant filings since 31 May 2026: 2 on litigation, 1 on court judgment or ruling and 1 on bank account frozen, and 1 other kind. The latest, on 22 Sep 2026: 关于公司诉讼收到一审判决书的公告.
自 31 May 2026 起有 8 份重大公告：litigation 2 份、court judgment or ruling 1 份、bank account frozen 1 份，另有 1 类。最新一份（22 Sep 2026）：关于公司诉讼收到一审判决书的公告。
5.0010.0015.0020.0025.00
Volume 成交量
1.23亿
20122015201920232026
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Medical Devices 医疗器械 · 140 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥32亿 | ¥47亿 | 40th lowest of 140 · 140 家中第 40 低 | |
| Trailing P/E 市盈率 | — | 40.2x | No value 无数据 | |
| P/B 市净率 | 2.0x | 2.4x | 52nd lowest of 140 · 140 家中第 52 低 | |
| Revenue Growth 营收增速 | -5.3% | 4.0% | 31st lowest of 140 · 140 家中第 31 低 | |
| Profit Growth 净利增速 | -67.6% | -2.6% | 23rd lowest of 140 · 140 家中第 23 低 | |
| Gross Margin 毛利率 | 43.4% | 55.2% | 45th lowest of 140 · 140 家中第 45 低 | |
| Net Margin 净利率 | -4.9% | 10.7% | 30th lowest of 140 · 140 家中第 30 低 | |
| Return on Equity 净资产收益率 | -0.4% | 2.4% | 29th lowest of 140 · 140 家中第 29 低 | |
| Debt to Assets 资产负债率 | 5.2% | 19.2% | 6th lowest of 140 · 140 家中第 6 低 | |
| Grade Score 评级得分 | 37 | 52 | 31st lowest of 140 · 140 家中第 31 低 |
Statement figures are for the period to 30 Jun 2026, filed by 140 of 140 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，140 家同业中 140 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics 迈瑞医疗 | ¥1,915亿 | 24.4x | 4.7x | 6.0% | 28.4% | 12.0% | C |
| Shanghai United Imaging Healthcare 联影医疗 | ¥871亿 | 49.2x | 4.0x | 17.2% | 12.6% | 4.1% | D |
| Shenzhen New Industries Biomedical 新产业 | ¥389亿 | 22.6x | 4.3x | 10.8% | 35.9% | 9.3% | B |
| APT Medical 惠泰医疗 | ¥343亿 | 36.8x | 11.1x | 25.7% | 34.6% | 16.0% | B |
| Wantai Biological 万泰生物 | ¥334亿 | — | 2.8x | 24.3% | -12.6% | -1.1% | D |
| Intco Medical Technology 英科医疗 | ¥320亿 | 28.1x | 1.7x | 40.6% | 13.1% | 4.5% | C |
| MGI Tech 华大智造 | ¥305亿 | — | 4.3x | 18.9% | -11.6% | -2.2% | D |
| Andon Health 九安医疗 | ¥275亿 | 6.2x | 1.2x | -30.6% | 578.7% | 13.7% | C |
| IRAY Group 奕瑞科技 | ¥264亿 | 36.7x | 3.4x | 56.7% | 25.0% | 6.4% | C |
| Jiangsu Yuyue Medical Equipment & Supply 鱼跃医疗 | ¥262亿 | 23.4x | 2.0x | -1.9% | 18.6% | 6.2% | C |
| Weigao Blood Purification 威高血净 | ¥215亿 | 43.8x | 1.8x | -0.4% | 13.1% | 3.2% | D |
| Lepu Medical Technology 乐普医疗 | ¥210亿 | 27.2x | 1.3x | -4.6% | 14.2% | 3.0% | D |
| Zhende Medical 振德医疗 | ¥198亿 | 71.7x | 3.5x | 5.9% | 6.8% | 2.5% | D |
| Autobio 安图生物 | ¥194亿 | 19.5x | 2.2x | -0.1% | 24.4% | 5.5% | C |
| Beijing Leadman Biochemistry 利德曼 | ¥32亿 | — | 2.0x | -5.3% | -4.9% | -0.4% | D |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。